Similar articles for PMID: 25848912

Year	Number of Results
1998	1
1999	3
2000	1
2001	3
2002	7
2003	8
2004	5
2005	6
2006	10
2007	7
2008	12
2009	10
2010	10
2011	6
2012	9
2013	8
2014	8
2015	10
2016	15
2017	12
2018	7
2019	8
2020	13
2021	8
2022	9
2023	2
2024	0

1

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD; EURODIAB Prospective Complications Study Group. Peeters SA, et al. Cardiovasc Diabetol. 2015 Mar 10;14:31. doi: 10.1186/s12933-015-0195-2. Cardiovasc Diabetol. 2015. PMID: 25848912 Free PMC article.

2

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Jorsal A, Parving HH, Tarnow L, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA. Peeters SA, et al. Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9. Cardiovasc Diabetol. 2017. PMID: 29070037 Free PMC article.

3

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.

Peeters SA, Engelen L, Buijs J, Jorsal A, Parving HH, Tarnow L, Rossing P, Schalkwijk CG, Stehouwer CDA. Peeters SA, et al. Cardiovasc Diabetol. 2017 Apr 26;16(1):55. doi: 10.1186/s12933-017-0539-1. Cardiovasc Diabetol. 2017. PMID: 28446168 Free PMC article.

4

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.

Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Nin JW, et al. Eur J Endocrinol. 2012 Feb;166(2):325-32. doi: 10.1530/EJE-11-0662. Epub 2011 Nov 29. Eur J Endocrinol. 2012. PMID: 22127490

5

[Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].

Florys B, Głowińska B, Urban M, Peczyńska J. Florys B, et al. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):184-9. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 17020653 Polish.

6

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.

Peeters SA, Engelen L, Buijs J, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA. Peeters SA, et al. J Diabetes Complications. 2018 Mar;32(3):325-329. doi: 10.1016/j.jdiacomp.2017.12.011. Epub 2018 Jan 3. J Diabetes Complications. 2018. PMID: 29395841

7

Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.

Jacqueminet S, Ben Abdesselam O, Chapman MJ, Nicolay N, Foglietti MJ, Grimaldi A, Beaudeux JL. Jacqueminet S, et al. Clin Chim Acta. 2006 May;367(1-2):103-7. doi: 10.1016/j.cca.2005.11.029. Epub 2006 Jan 19. Clin Chim Acta. 2006. PMID: 16426593

8

Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction.

Muniz JJ, Lacchini R, Belo VA, Nobre YT, Tucci S Jr, Martins AC, Tanus-Santos JE. Muniz JJ, et al. Int J Impot Res. 2012 Jan-Feb;24(1):38-43. doi: 10.1038/ijir.2011.44. Epub 2011 Sep 15. Int J Impot Res. 2012. PMID: 21918531

9

Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level.

Komosinska-Vassev K, Olczyk P, Winsz-Szczotka K, Kuznik-Trocha K, Klimek K, Olczyk K. Komosinska-Vassev K, et al. Gerontology. 2011;57(1):44-52. doi: 10.1159/000295775. Epub 2010 Mar 9. Gerontology. 2011. PMID: 20215736

10

Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.

Maxwell PR, Timms PM, Chandran S, Gordon D. Maxwell PR, et al. Diabet Med. 2001 Oct;18(10):777-80. doi: 10.1046/j.1464-5491.2001.00542.x. Diabet Med. 2001. PMID: 11678966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

181 results

Results by year